BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 29692255)

  • 41. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sclerosing skin diseases].
    Sticherling M
    Internist (Berl); 2019 Aug; 60(8):783-791. PubMed ID: 31292667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The frequency of pulmonary hypertension in patients with juvenile scleroderma.
    Adrovic A; Oztunc F; Barut K; Koka A; Gojak R; Sahin S; Demir T; Kasapcopur O
    Bosn J Basic Med Sci; 2015 Aug; 15(4):30-5. PubMed ID: 26614849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
    Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Musculoskeletal MRI findings of juvenile localized scleroderma.
    Eutsler EP; Horton DB; Epelman M; Finkel T; Averill LW
    Pediatr Radiol; 2017 Apr; 47(4):442-449. PubMed ID: 28091699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathohistological and histochemical changes in the skin of patients with scleroderma during treatment at the Sochi spa].
    Al'ter SM
    Vestn Dermatol Venerol; 1971 Oct; 45(10):40-3. PubMed ID: 5134077
    [No Abstract]   [Full Text] [Related]  

  • 54. Polymorphic fibrosing reaction mimicking keloidal scleroderma but without associated classic scleroderma.
    Labandeira J; León-Mateos A; Suárez-Peñaranda JM; Garea MT; Toribio J
    Dermatology; 2003; 207(2):204-5. PubMed ID: 12920378
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localized cutaneous scleroderma.
    Krafchik BR
    Semin Dermatol; 1992 Mar; 11(1):65-72. PubMed ID: 1550717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Scleroderma: an update on the pathogenesis and treatment].
    Garza-Rodríguez V; Villarreal-Alarcón MA; Ocampo-Candiani J
    Rev Med Inst Mex Seguro Soc; 2013; 51(1):50-7. PubMed ID: 23550408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histological and rheological grading of cutaneous sclerosis in scleroderma.
    Piérard GE
    Dermatologica; 1989; 179(1):18-20. PubMed ID: 2767293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Localized scleroderma (morphea) in childhood].
    Weibel L
    Hautarzt; 2012 Feb; 63(2):89-96. PubMed ID: 22290277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.